Cover Image

Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment

Khalid Altigani Ahmed,1 Alnada Ibrahim,2 Daniel Gonzalez,3 Abubakr O Nur4 1Department of Clinical Pharmacy, College of Pharmacy, Najran University, Najran, Saudi Arabia; 2Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 3Divisio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed KA (Author), Ibrahim A (Author), Gonzalez D (Author), Nur AO (Author)
Format:	Book
Published:	Dove Medical Press, 2024-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
by: Sixuan Zhao, et al.
Published: (2021)

Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children
by: Xianhuan Shen, et al.
Published: (2024)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
by: Lingling Ye, et al.
Published: (2022)

Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients
by: Lucie Polášková, et al.
Published: (2024)

Population Pharmacokinetic/Pharmacodynamic Modelling of Daptomycin for Schedule Optimization in Patients with Renal Impairment
by: Teresa García-Martínez, et al.
Published: (2022)

Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
by: Yang Chu, et al.
Published: (2020)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
by: Kui-fen Ma, et al.
Published: (2020)

Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
by: Muhammad Muaaz Munir, et al.
Published: (2021)

Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function
by: De-Yi Li, et al.
Published: (2021)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
by: Wen-Qian Fu, et al.
Published: (2022)

Reference intervals for serum creatinine and urea in the adult western Sudanese population
by: Muaath Ahmed Mohammed, et al.
Published: (2024)

Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis
by: Zhenwei Yu, et al.
Published: (2023)

Optimizing Vancomycin Dosing in Chronic Kidney Disease by Deriving and Implementing a Web-Based Tool Using a Population Pharmacokinetics Analysis
by: Sreemanee Raaj Dorajoo, et al.
Published: (2019)

Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
by: Romain Garreau, et al.
Published: (2021)

Population Pharmacokinetics of Vancomycin in Pregnant Women
by: Rahul K. Goyal, et al.
Published: (2022)

Genetic Algorithms as a Tool for Dosing Guideline Optimization: Application to Intermittent Infusion Dosing for Vancomycin in Adults
by: Pieter J. Colin, et al.
Published: (2020)

A Comprehensive Physiologically Based Pharmacokinetic Model for Predicting Vildagliptin Pharmacokinetics: Insights into Dosing in Renal Impairment
by: Mahnoor Pasha, et al.
Published: (2024)

Population pharmacokinetic model of vancomycin in postoperative neurosurgical patients
by: Shifeng Wei, et al.
Published: (2022)

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications
by: Jan Miroslav Hartinger, et al.
Published: (2023)

Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
by: He S, et al.
Published: (2022)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
by: Mwila Mulubwa, et al.
Published: (2020)

Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes
by: Yoshiko Tomita, et al.
Published: (2022)

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
by: Tao Zhang, et al.
Published: (2020)

Dose optimization of vancomycin in obese patients: A systematic review
by: Mahmoud E. Elrggal, et al.
Published: (2023)

Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis
by: Jianwen Xu, et al.
Published: (2022)

Population pharmacokinetics and dose optimization of magnesium sulfate in Chinese preeclampsia population
by: Jing Deng, et al.
Published: (2024)

Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers
by: Kevin J. Downes, et al.
Published: (2023)

Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
by: Noppaket Singkham, et al.
Published: (2022)

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection
by: Zhi LJ, et al.
Published: (2018)

Population Pharmacokinetics and Dose Optimization of Ganciclovir in Critically Ill Children
by: SiChan Li, et al.
Published: (2021)

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024)

Population Pharmacokinetics and Dosing Regimen Optimization of Latamoxef in Chinese Children
by: Yang Wang, et al.
Published: (2022)

Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series
by: IfeanyiChukwu O. Onor, et al.
Published: (2020)

Population pharmacokinetics of vancomycin in very low birth weight neonates
by: Abdullah Alsultan, et al.
Published: (2023)

Pharmacokinetics of Vancomycin in Healthy Korean Volunteers and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients with Normal Renal Function
by: Yong Kyun Kim, et al.
Published: (2024)

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
by: Eliška Dvořáčková, et al.
Published: (2023)

Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model‐informed precision dosing trial simulations
by: Abdullah Aljutayli, et al.
Published: (2022)

External Evaluation of Vancomycin Population Pharmacokinetic Models at Two Clinical Centers
by: Yi-Xi Liu, et al.
Published: (2021)

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
by: Chuhui Wang, et al.
Published: (2021)

Morphological Study of Palatal Rugae in a Sudanese Population
by: Altayeb Abdalla Ahmed, et al.
Published: (2015)